Jia Jie Biomedical Co., Ltd. (TPEX:4109)

Market Cap	1.36B -34.2%
Revenue (ttm)	487.66M -4.4%
Net Income	55.20M -73.9%
EPS	0.46 -77.7%
Shares Out	118.74M
PE Ratio	24.69
Forward PE	n/a
Dividend	0.20 (1.77%)
Ex-Dividend Date	n/a

Volume	139,272
Open	11.45
Previous Close	11.45
Day's Range	11.45 - 11.60
52-Week Range	10.35 - 18.80
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Jia Jie Biomedical

Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It also involved in the wholesa...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1995
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4109

Financial Performance

In 2025, Jia Jie Biomedical's revenue was 485.40 million, a decrease of -9.62% compared to the previous year's 537.07 million. Earnings were 50.26 million, a decrease of -76.22%.